An investment consortium, comprising of Elliott Investment Management, Patient Square Capital and Veritas Capital, has agreed to take Syneos Health Inc private for $4.46 billion, the contract ...

In trading on Tuesday, shares of Syneos Health Inc (Symbol: SYNH) entered into oversold territory, hitting an RSI reading of 29.4, after changing hands as low as $45.94 per share.

Shareholders to Receive $43.00 Per Share in Cash Represents 24% Premium to Unaffected Stock Price MORRISVILLE, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos ...

Syneos Health expects full-year earnings in the range of $3.26 to $3.53 per share, with revenue in the range of $4.97 billion to $5.18 billion. _____ This story was generated by Automated Insights ...

Syneos by Business North Carolina — May 5, 2023 . CHARLOTTE – Morrisville-based Syneos Health has tapped Michael Bonello as its next chief financial officer.

Syneos Health received an acquisition offer from a PE consortium of c.$7.1 billion. The transaction involves an all-cash consideration of $43.00 per share, a 1.7% premium over SYNH's stock price ...

Syneos Health Inc <SYNH.O>, a U.S. contract research organization (CRO) that serves the pharmaceutical industry, is exploring a sale, people familiar with the matter said on Monday.

SYNEOS HEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Syneos Health, Inc. - SYNH May 10 ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Syneos Health, Inc. (NASDAQ: SYNH) to a consortium of affiliates o ...

NEW YORK, March 7, 2019 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Syneos Health, Inc. ('Syneos' or the 'Comp ...

In trading on Tuesday, shares of Syneos Health Inc (Symbol: SYNH) entered into oversold territory, hitting an RSI reading of 28.5, after changing hands as low as $67.92 per share.